tirzepatide semaglutide equivalent dose Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are transitioning from semaglutide to tirzepatide

while all three treated groups had benefits as assessed by looking at liver fat area and triglycerides, the Sema + -MSTN/-ActA combination (which had the largest decreases in overall body fat composition) also had the largest benefits in terms of these liver measures (Fig

The scientific research on this topic is still developing , but this article will review existing evidence, patient experiences, and medical insights to help readers better understand the possible effects

Today, were comparing semaglutide and tirzepatide to help you understand how they work and which option may best meet your needs

Individual outcomes are not guaranteed and depend on clinical eligibility, biology, and lifestyle factors